13 institutions hold shares in SenesTech Inc. (SNES), with 79.24k shares held by insiders accounting for 1.93% while institutional investors hold 5.90% of the company’s shares. The shares outstanding are 8.07M, and float is at 3.81M with Short Float at 10.48%. Institutions hold 5.78% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Gilder, Gagnon, Howe & Co. with over 36900.0 shares valued at $69372.0. The investor’s holdings represent 0.82% of the SNES Shares outstanding. As of Dec 30, 2020, the second largest holder is TCI Wealth Advisors, Inc. with 3401.0 shares valued at $5866.0 to account for 0.08% of the shares outstanding. The other top investors are Bank of Montreal/Can/ which holds 1500.0 shares representing 0.03% and valued at over $2820.0, while CWM, LLC holds 0.01% of the shares totaling 500.0 with a market value of $862.0.
SenesTech Inc. (NASDAQ: SNES) is 18.26% higher on its value in year-to-date trading and has touched a low of $1.32 and a high of $4.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SNES stock was last observed hovering at around $2.03 in the last trading session, with the day’s gains setting it 0.01% off its average median price target of $4.00 for the next 12 months. It is also 49.0% off the consensus price target high of $4.00 offered by 1 analysts, but current levels are 49.0% higher than the price target low of $4.00 for the same period.
Currently trading at $2.04, the stock is -2.65% and 9.61% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.16 million and changing 0.49% at the moment leaves the stock 13.59% off its SMA200. SNES registered -53.85% loss for a year compared to 6-month gain of 20.00%. The firm has a 50-day simple moving average (SMA 50) of $2.0167 and a 200-day simple moving average (SMA200) of $1.7103.
The stock witnessed a -5.99% loss in the last 1 month and extending the period to 3 months gives it a 48.91%, and is -7.69% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.63% over the week and 11.19% over the month.
SenesTech Inc. (SNES) has around 34 employees, a market worth around $8.30M and $0.20M in sales. Distance from 52-week low is 54.55% and -54.63% from its 52-week high. The company has generated returns on investments over the last 12 months (-367.40%).
SenesTech Inc. (SNES) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for SenesTech Inc. (SNES) is a “Buy”. 1 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
SenesTech Inc. is expected to release its quarterly report on 05/19/2021 and quarterly earnings per share for the current quarter are estimated at -$0.52 with sales reaching $80k over the same period.The EPS is expected to grow by 39.10% this year, but quarterly earnings will post 165.70% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
SenesTech Inc. (SNES) Insider Activity
A total of 0 insider transactions have happened at SenesTech Inc. (SNES) in the last six months, with sales accounting for 0 and purchases happening 0 times.
SenesTech Inc. (SNES): Who are the competitors?
The company’s main competitors (and peers) include Pieris Pharmaceuticals Inc. (PIRS) that is trading -27.55% down over the past 12 months. Short interest in the company’s stock has risen 70.27% from the last report on Dec 30, 2020 to stand at a total of 0.12 million short shares sold with a short interest ratio of 0.9.